University of Iowa starts Phase II trials with Ad/PSA vaccine

A research team at the University of Iowa is seeking patients to enroll in Phase II clinical trials of a new form of vaccine immunotherapeutic to treat men with recurrent prostate cancer. … READ MORE …

New prostate cancer “vaccine” effective in Phase I trial

While we are all waiting for the approval of Provenge, it is worth noting that a research group at the University of Iowa has developed a very different type of prostate cancer treatment based on older technology. … READ MORE …